Summary
Bone marrow biopsy (BMB) is a routine investigation in the diagnosis and staging of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL), and there is evidence supporting its prognostic importance in some histological varieties. The histological characteristics of BMB in 433 NHL and 155 HD patients were reviewed for clinicopathological correlations; 36 of these cases were also studied by means of immunohistochemistry. BM infiltrates were discovered in 171 NHL patients. In 36 cases, the diagnosis of NHL was directly established by BMB; a discordance between lymph node and BM histology was observed in 38 of the other 135 cases. BM-positive centroblastic and immunoblastic NHL were significantly associated with larger infiltrates, BM fibrosis, and megakaryocytic hyperplasia. Leukemization at diagnosis was more frequent in low-malignancy NHL. No correlation was found between histology and prognosis, although immunohistochemistry revealed a B-cell phenotype in all but two cases. BMB was positive in 18 of the 155 HD patients and directly diagnostic in two; Reed-Sternberg and Hodgkin cells were CD-30 positive and surrounded by T-cell infiltration. The concordance between BM and lymph node histology was fairly satisfactory, although the relationships between BM infiltration and other histological parameters may reflect peculiar interactions with BM microenvironmental factors. The usefulness of BMB in the diagnosis of malignant lymphomas has been demonstrated, and further progress can be expected from the availability of reliable immunohistochemical markers of clonality reacting on paraffin-embedded BM sections.
Similar content being viewed by others
References
Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R (1982) Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 51: 345–360
Bartl R, Frisch B, Burkhardt R, Kettner G, Mahl G, Fateh-Moghadam A, Sund M (1982) Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br J Haematol 51: 511–530
Bartl R, Frisch B, Burkhardt R, Jaeger K, Pappenberger R, Hoffmann-Fezer G (1984) Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol 37: 233–254
Bartl R, Hansmann ML, Frisch B, Burkhardt R (1988) Comparative histology of malignant lymphomas in lymph node and bone marrow. Br J Haematol 69: 229–237
Bennett JM, Cain KC, Glick JH, Johnson GJ, Ezdinli E, O'Connell MJ (1986) The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol 4: 1462–1469
Berti E, Aversa G, Soligo D, Cattoretti G, Delia D, Aiello A, Parravicini C, Hall BM, Caputo R (1991) A6: A new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues. Am J Clin Pathol 95: 188–193
Burkhardt R, Frisch B, Bartl R (1982) Bone biopsy in haematological disorders. J Clin Pathol 35: 257–284
Cimino G, Anselmo AP, De Luca AM, Fidani P, Mauro F, Marzullo A, Maurizi Enrici R, Papa G (1983) Bone marrow involvement at the onset of Hodgkin's disease. Tumori 69: 47–51
Conlan MG, Bast M, Armitage JO, Weisenburger DD (1990) Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. J Clin Oncol 8: 1163–1172
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229
Dalchau R, Flanagan BF, Fabre JW (1986) Structural implications of the location and stability to proteolytic enzymes of immunodominant determinants of the human leukocyte common molecule. Eur J Immunol 16: 993–999
Ellis ME, Diehl LF, Granger E, Elson E (1989) Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30: 115–120
Foucar K, McKenna RW, Frizzera G, Brunning RD (1982) Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer 49: 888–897
Horny HP, Engst U, Walz RS, Kaiserling E (1989) In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol 71: 313–321
Jagannath S, Velasquez WS, Tucker SL, etal. (1985) Stage IV diffuse large-cell lymphoma: a long-term analysis. J Clin Oncol 3: 39–47
Kluin PM, van Krieken JH, Kleiverda K, Kluin-Nelemans HC (1990) Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies. Am J Clin Pathol 94: 59–66
Lennert K, Mohri N, Stein H, Kaiserling E (1975) The histopathology of malignant lymphoma. Br J Haematol 31 [Suppl]: 193–203
Parwaresch MR, Radzun HJ, Kreipe H, Hansmann ML, Barth EJ (1986) Monocyte-macrophage reactive monoclonal antibody Kim6 recognizes an intracytoplasmatic antigen. Am J Pathol 125: 141–151
Pileri S, Falini B, Sabattini E, Bigerna B, Gherlinzoni F, Tazzari PL (1991) Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. Haematologica (Pavia) 76: 226–234
Schwarting R, Gesdes J, Durkop H, Falini B, Pileri S, Stein H (1989) BerH2: a new anti Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74: 1678–1689
Siegelman MH, Cleary ML, Warnke R, Sklar J (1985) Frequent biclonality and Ig gene alterations among B-cell lymphomas that show multiple histologic forms. J Exp Med 161: 850–863
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lambertenghi-Deliliers, G., Annaloro, C., Soligo, D. et al. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol 65, 61–65 (1992). https://doi.org/10.1007/BF01698130
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01698130